Podcast
November 28, 2023
Showing 11 - 20 of 108 results
JAMDA
November 23, 2023
The Impact of State Dementia Training Requirements for Nursing Homes on Antipsychotic Medication Use
Nursing home (NH) staff often report not having adequate dementia-specific knowledge to effectively care for these residents. Between 2011 and 2019, 9 states in the United States implemented dementia training requirements for NH staff. This study evaluated whether the state-mandated dementia training for N...
JAMDA
November 18, 2023
A Novel Home-Based Medication Management Program and Its Influence on Hospitalization Rates among Home Health Care Recipients
Patients do not take their medicine as prescribed 50% of the time, and of medication-related hospital admissions in the United States, 33% to 69% are due to poor medication adherence, at a cost of approximately $100 billion a year. Continue CareRx (CCRx) is a novel home-based medication management program ...
JAMDA
October 29, 2023
Challenges in Deprescribing among Older Adults in Post-Acute Care Transitions to Home
Medications with a higher risk of harm or that are unlikely to be beneficial are used by nearly all older patients in home health care (HHC). The objective of this study was to understand stakeholders’ perspectives on challenges in deprescribing these medications for post-acute HHC patients.
Podcast
October 6, 2023
JAMDA On-The-Go | September 2023
Podcast
October 5, 2023
JAMDA On-The-Go | August 2023
JAMDA
September 25, 2023
Antipsychotic Drug Reduction through the Implementation of a Neurologically Oriented, Interdisciplinary Psycho-Diagnostic and Antipsychotic Stewardship Program
Antipsychotic utilization in skilled nursing facilities (SNFs) is a major focus of regulatory compliance and a key theme in resident care. This created opportunities for innovations in clinical care of behavioral and psychological symptoms of dementia (BPSD). In a shared initiative with one of our SNF oper...
JAMDA
August 12, 2023
Deprescribing Interventions for Older Patients: A Systematic Review and Meta-Analysis
Deprescribing reduces polypharmacy in older adults. A thorough study of the effect of deprescribing interventions on clinical outcomes in older adults is presently lacking. As a result, we evaluated the impact of deprescribing on clinical outcomes in older patients.
JAMDA
August 4, 2023
Long-Term Opioid Use and Dementia Risk in Patients With Chronic Pain
This study aimed to investigate the association between long-term opioid use and the risk of dementia in patients with chronic pain.
Spotlight
July 27, 2023
The Past, Present, and Future of Deprescribing
AMDA’s Drive to Deprescribe (D2D) initiative put practitioners behind the wheel on medication optimization. During a recent AMDA On-The-Go podcast, guest host Jennifer Pruskowski, PharmD, MS, BCPS, BCGP, CPE, sat down with Michael Steinman, MD, co-director of the U.S. Deprescribing Research Network, to tal...
Tools, knowledge, and recognition to improve vaccination rates and protect residents and staff.
